» Articles » PMID: 12966536

Early Events of SARS Coronavirus Infection in Vero Cells

Overview
Journal J Med Virol
Specialty Microbiology
Date 2003 Sep 11
PMID 12966536
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

An isolate from a patient in the recent severe acute respiratory syndrome (SARS) outbreak in Singapore was used to infect Vero E6 cells. This study concentrated on the first 30 min of infection. It was discovered that the SARS coronavirus attached, entered, and uncoated the nucleocapsids, all within a 30-min period. At 5 min after infection, several virus particles lined the Vero cell plasma membrane. Virus particles were at various stages of fusion at the cell surface, since entry was not a synchronised process. After entry (10 and 15 min), spherical core particles moved into the cytoplasm within large vacuoles. Quite surprising at such early stages of infection (20 min), a virus-induced change in the infected cells was evident. The induction of myelin-like membrane whorls was obvious within the same vacuoles as the core particles. The significance of this virus-induced change is unknown at this stage. By 25-30 min postinfection (p.i.), the spherical core particles appeared to be disassociating and, in their place, doughnut-shaped electron-dense structures were observed. These could be the virus genomes together with the helical nucleocapsids. They were no longer in large vacuoles but packaged into smaller vacuoles in the cytoplasm, and occasionally in small groups.

Citing Articles

Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells.

Merigo F, Lotti V, Bernardi P, Conti A, Clemente A, Ligozzi M Int J Mol Sci. 2022; 23(17).

PMID: 36077122 PMC: 9455986. DOI: 10.3390/ijms23179724.


Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells.

Yang H, Yuan H, Zhao X, Xun M, Guo S, Wang N Virol Sin. 2022; 37(3):380-389.

PMID: 35272059 PMC: 8900885. DOI: 10.1016/j.virs.2022.03.003.


Known Cellular and Receptor Interactions of Animal and Human Coronaviruses: A Review.

Everest H, Stevenson-Leggett P, Bailey D, Bickerton E, Keep S Viruses. 2022; 14(2).

PMID: 35215937 PMC: 8878323. DOI: 10.3390/v14020351.


SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System.

Barreto-Vieira D, da Silva M, de Almeida A, Rasinhas A, Monteiro M, Miranda M Viruses. 2022; 14(2).

PMID: 35215794 PMC: 8879486. DOI: 10.3390/v14020201.


A phenomics approach for antiviral drug discovery.

Rietdijk J, Tampere M, Pettke A, Georgiev P, Lapins M, Warpman-Berglund U BMC Biol. 2021; 19(1):156.

PMID: 34334126 PMC: 8325993. DOI: 10.1186/s12915-021-01086-1.


References
1.
Ruan Y, Wei C, Ee A, Vega V, Thoreau H, Su S . Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet. 2003; 361(9371):1779-85. PMC: 7140172. DOI: 10.1016/s0140-6736(03)13414-9. View

2.
Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

3.
Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H, Becker S . Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1967-76. DOI: 10.1056/NEJMoa030747. View

4.
Rota P, Oberste M, Monroe S, Nix W, Campagnoli R, Icenogle J . Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003; 300(5624):1394-9. DOI: 10.1126/science.1085952. View

5.
Marra M, Jones S, Astell C, Holt R, Brooks-Wilson A, Butterfield Y . The Genome sequence of the SARS-associated coronavirus. Science. 2003; 300(5624):1399-404. DOI: 10.1126/science.1085953. View